Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Prospective Study Comparing the Safety and Efficacy of ABT-335 in Combination With Atorvastatin and Ezetimibe to Atorvastatin in Combination With Ezetimibe in Subjects With Combined (Atherogenic) Dyslipidemia

NCT00639158 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00639158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00639158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Prospective Study Comparing the Safety and Efficacy of ABT-335 in Combination With Atorvastatin and Ezetimibe to Atorvastatin in Combination With Ezetimibe in Subjects With Combined (Atherogenic) Dyslipidemia
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2008
Completion date
Not reported
Enrollment
543 (actual)
Sites
118

Conditions

As the registry lists them; a condition with its own page is linked.

combined (atherogenic) dyslipidemia, coronary heart disease, dyslipidemias, mixed dyslipidemia